Showing results (191-200 of 434) with videos related to

Sort By:
Pageof 44
Molecular and Cellular Endocrinology|May 1, 1987
Stimulation of luteinizing hormone release by melittin and phospholipase A2 in rat pituitary cellsL Kiesel, T Rabe, G Hauser, et al.
Human Reproduction (Oxford, England)|November 6, 1998
Aneuploidy in human granulosa lutein cells obtained from gonadotrophin-stimulated follicles and its relation to intrafollicular hormone concentrationsK Grunwald, K Feldmann, P Melsheimer, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 1, 1996
Role of leukotriene C4 in follicle-stimulating hormone (FSH) secretion in female rat pituitaryA Przylipiak, T Rabe, L Kiesel, et al.
Molecular and Cellular Endocrinology|May 1, 1988
Epidermal growth factor stimulates luteinizing hormone and arachidonic acid release in rat pituitary cellsA Przylipiak, L Kiesel, T Rabe, et al.
Zentralblatt Fur Gynakologie|January 1, 1993
[Clinical results of pediatric gynecologic consultation at the Heidelberg University Gynecologic Clinic]B Röpke-Brandt, I Gerhard
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|August 18, 2001
[Complementary medicine and patient contentedness - a survey]K W Freivogel, I Gerhard
Journal of Cancer Research and Clinical Oncology|May 18, 2010
Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgeryThea Laurentius, Annelore Altendorf-Hofmann, Oumar Camara, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 29, 1998
Influence of leukotrienes on in vitro growth of human mammary carcinoma cell line MCF-7A Przylipiak, J Hafner, J Przylipiak, et al.
Fertility and Sterility|September 1, 1993
Evaluation of polyacrylamide gel as substitute for human cervical mucus in the sperm penetration testW Eggert-Kruse, B Schwalbach, G Rohr, et al.
Pharmacogenetics|April 3, 2002
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 yearsShan Wang-Gohrke, Heiko Becher, Rolf Kreienberg, et al.
Pageof 44